lifitegrast 5 % Ophthalmic Solution

RxCUI: 1801835
RxNorm name: lifitegrast 5 % Ophthalmic Solution
Display name: lifitegrast 5 % Ophthalmic Solution
Full name: lifitegrast 5 % Ophthalmic Solution
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xiidra	LIFITEGRAST	Novartis Pharmaceuticals Corporation	8589d376-ac10-4ddb-9c53-2e0c8d5675c4	2025-08-18	Adverse reactions	Exact identifier rxcui: 1801835
Xiidra	LIFITEGRAST	Bausch & Lomb Incorporated	1a914080-a3c0-44be-b601-0ae3160e77eb	2024-11-21	Adverse reactions	Exact identifier rxcui: 1801835
Lifitegrast	LIFITEGRAST	Aurobindo Pharma Limited	1d4b4b61-79da-4b6f-bb19-056d111bf400	2023-11-13	Adverse reactions	Exact identifier rxcui: 1801835

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
8589d376-ac10-4ddb-9c53-2e0c8d5675c4	lifitegrast 5 % Ophthalmic Solution [PSN] · lifitegrast 50 MG/ML Ophthalmic Solution [SCD] · lifitegrast 5 % Ophthalmic Solution [SY]	3	6	These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016	20250818
1a914080-a3c0-44be-b601-0ae3160e77eb	lifitegrast 5 % Ophthalmic Solution [PSN] · lifitegrast 50 MG/ML Ophthalmic Solution [SCD] · lifitegrast 5 % Ophthalmic Solution [SY]	3	5	These highlights do not include all the information needed to use XIIDRA safely and effectively. See full prescribing information for XIIDRA. XIIDRA ® (lifitegrast ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 2016	20241121
1d4b4b61-79da-4b6f-bb19-056d111bf400	lifitegrast 5 % Ophthalmic Solution [PSN] · lifitegrast 50 MG/ML Ophthalmic Solution [SCD] · lifitegrast 5 % Ophthalmic Solution [SY]	3	1	These highlights do not include all the information needed to use LIFITEGRAST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LIFITEGRAST OPHTHALMIC SOLUTION. LIFITEGRAST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2016	20231113